Eli Lilly and Company (LLY)

Index:

S&P 100

$ 839.96
   
  • Change Today:
    $105.06
  • 52 Week High: $960.02
  • 52 Week Low: $720.91
  • Currency: US Dollars
  • Shares Issued: 948.17m
  • Volume: 10,853,385
  • Market Cap: $796,425m
  • RiskGrade: 179
  • Beta: 0.76

LLY Overview

Founded in 1876, Eli Lilly is now a leading company involved in the discovery, development, manufacture and sale of pharmaceutical products. Headquartered in Indianapolis, the group's extensive portfolio of pharmaceutical products encompasses numerous areas, including neuroscience, endocrinology, oncology, animal health and other products for livestock and poultry, cardiovascular and anti-infectives. The company employs more than 43,000 people worldwide and sells its products in approximately 140 countries.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 28.2%
ROCE 35.2%
Latest F'cast
P/E 71.4
PEG 0.7
Pr/Revenue 17.7
Pr/Book 55.8
Latest F'cast
Revenue 32.0%
PBT 93.5%
EPS 102.1%
DPS n/a

LLY Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 24,539.80 7,229.90 682.00¢ 24.8 0.7 +37% 307.00¢ 1.8%
31-Dec-21 28,318.40 6,155.50 615.00¢ 44.9 n/a -10% 353.00¢ 1.3%
31-Dec-22 28,541.40 6,806.40 693.00¢ 52.8 4.1 +13% 407.00¢ 1.1%
31-Dec-23 34,124.10 6,554.60 582.00¢ 100.2 n/a -16% n/a 0.0%
31-Dec-24 45,042.70 12,680.40 1,176.00¢ 65.6 0.6 +102% n/a 0.0%

LLY Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 59,537.45 25,535.19 2,320.07¢ 36.2 0.4 +97% 616.24¢ 0.0%
31-Dec-26 71,089.02 32,295.36 2,967.50¢ 28.3 1.0 +28% 636.16¢ 0.0%
31-Dec-27 83,186.08 39,316.54 3,693.24¢ 22.7 0.9 +24% 724.47¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

LLY ShareCast News

Lilly shares jump on positive results from oral ... 17-Apr-2025 ShareCast
Weight-loss drugs swell revenues at Eli Lilly 06-Feb-2025 ShareCast
Eli Lilly weight-loss drug Zepbound beats Wegovy... 04-Dec-2024 ShareCast

LLY Top Newspaper Links

Patents Ending, Eli Lilly Chases New Drugs 01-Oct-2010 New York Times
Botox maker to pay $600M to resolve federal inve... 02-Sep-2010 USA Today
Eli Lilly posts 3rd-quarter profit but analysts ... 22-Oct-2009 Chicago Tribune

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

LLY Market Data

Currency US Dollars
Share Price $ 839.96
Change Today $ 105.06
% Change 14.30 %
52 Week High $960.02
52 Week Low $720.91
Volume 10,853,385
Shares Issued 948.17m
Market Cap $796,425m
Beta 0.76
RiskGrade 179

What The Brokers Say

Strong Buy 11
Buy 10
Neutral 5
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Apr-2025

Time Volume / Share Price
16:00 1,798 @ $839.47
16:00 100 @ $839.47
15:59 113 @ $839.45
15:59 200 @ $839.46
15:59 287 @ $839.50

Top of Page